PET imaging CCR2 in Pancreatic ductal adenocarcinoma

被引：0
|
作者：
Zhang, Xiaohui [1 ]
Detering, Lisa [1 ]
Sultan, Deborah [1 ]
Luehmann, Hannah [1 ]
Li, Lin [2 ]
Heo, Gyu Seong [1 ]
Grierson, Patrick [2 ]
Frye, Jennifer [1 ]
Kaemmerer, Helen [1 ]
Ruzinova, Marianna [3 ]
Laforest, Richard [1 ]
Lim, Kian [2 ]
Dehdashti, Farrokh [1 ]
Liu, Yongjian [1 ]
机构：
[1] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA
[2] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
405
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Multiplex imaging reveals features of organotropism in pancreatic ductal adenocarcinoma
    Eng, Jennifer
    Link, Jason
    Pelz, Carl
    Sears, Rosalie
    CANCER RESEARCH, 2023, 83 (02)
  • [32] Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
    Koustoulidou, S.
    Knight, J. C.
    Kersemans, V.
    O'Neill, E.
    Cornelissen, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S230 - S230
  • [33] Pancreatic cysts: What imaging characteristics are associated with development of pancreatic ductal adenocarcinoma?
    Paroder, Viktoriya
    Flusberg, Milana
    Kobi, Mariya
    Rozenblit, Alla M.
    Chernyak, Victoria
    EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (09) : 1622 - 1626
  • [34] Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review
    Khaled Y. Elbanna
    Hyun-Jung Jang
    Tae Kyoung Kim
    Insights into Imaging, 11
  • [35] Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review
    Elbanna, Khaled Y.
    Jang, Hyun-Jung
    Kim, Tae Kyoung
    INSIGHTS INTO IMAGING, 2020, 11 (01)
  • [36] Inhibition of CCR2 potentiates the checkpoint inhibitor immunotherapy in pancreatic cancer
    Jung, Heiyoun
    Ertl, Linda
    Janson, Christine
    Schall, Thomas
    Charo, Israel
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [37] CCR2 Signaling Inhibition Improves Tumor Control in Pancreatic Cancer
    Mitchem, J.
    Sanford, D.
    Porembka, M.
    Lin, G.
    Goedegebuure, S. P.
    Linehan, D. C.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S44 - S44
  • [38] PET/CT imaging of pancreatic ductal adenocarcinoma with a claudin-4 binding peptide in preclinical mouse model
    Seo, Jai Woong
    Wang, James
    Kare, Aris J.
    Tumbale, Spencer K.
    Wu, Bo
    Raie, Marina N.
    Pandrala, Mallesh
    Ferrara, Katherine W.
    CANCER RESEARCH, 2024, 84 (06)
  • [39] CCR1 and CCR2 Antagonists
    Zimmermann, Henning W.
    Sterzer, Viktor
    Sahin, Hacer
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (13) : 1539 - 1552
  • [40] Pancreatic Ductal Adenocarcinoma Derived From IPMN and Pancreatic Ductal Adenocarcinoma Concomitant With IPMN
    Yamaguchi, Koji
    Kanemitsu, Shuichi
    Hatori, Takashi
    Maguchi, Hiroyuki
    Shimizu, Yasuhiro
    Tada, Minoru
    Nakagohri, Toshio
    Hanada, Keiji
    Osanai, Manabu
    Noda, Yutaka
    Nakaizumi, Akihiko
    Furukawa, Toru
    Ban, Shinichi
    Nobukawa, Bunsei
    Kato, Yo
    Tanaka, Masao
    PANCREAS, 2011, 40 (04) : 571 - 580
12345